Viking Therapeutics (NASDAQ:VKTX) Posts Earnings Results, Beats Expectations By $0.01 EPS : vimarsana.com

Viking Therapeutics (NASDAQ:VKTX – Get Free Report) announced its quarterly earnings data on Wednesday. The biotechnology company reported ($0.26) EPS for the quarter, beating analysts’ consensus estimates of ($0.27) by $0.01, Briefing.com reports. During the same period in the previous year, the company posted ($0.25) earnings per share. Viking Therapeutics Trading Up 0.5 % Shares […]

Related Keywords

Sarah Kathryn Rouan , Raymond James , William Blair , Jefferies Financial Group , Securities Exchange Commission , Therapeutics Inc , Nasdaq , Maxim Group , Viking Therapeutics , Get Free Report , Financial Group , Director Sarah Kathryn Rouan , Exchange Commission , Viking Therapeutics Daily , Nasdaq Vktx , Vktx , Medical , Earnings ,